Literature DB >> 27586587

Mitochondrial quality control by the Pink1/Parkin system.

Cornelia Rüb1, Anne Wilkening1, Wolfgang Voos2.   

Abstract

Mitochondrial dysfunction represents a prominent pathological feature in many neurodegenerative diseases, particularly in Parkinson's disease (PD). Mutations in the genes encoding the proteins Pink1 and Parkin have been identified as genetic risk factors in familiar cases of PD. Research during the last decade has identified both proteins as crucial components of an organellar quality control system that contributes to the maintenance of mitochondrial function in healthy cells. The Pink1/Parkin system acts as a sensor for mitochondrial quality and is activated, in particular, after the loss of the electric potential across the inner mitochondrial membrane. Pink1 molecules accumulate at the surface of damaged mitochondria to recruit and activate Parkin, which, in turn, elicits a signaling pathway eventually leading to the autophagic removal of the damaged organelles. This review summarizes recent advances in our knowledge of the functional role of the Pink1/Parkin system in preventing the accumulation of damaged mitochondria by mitophagy.

Entities:  

Keywords:  Mitochondria; Mitophagy; Organellar quality control; Parkin; Pink1

Mesh:

Substances:

Year:  2016        PMID: 27586587     DOI: 10.1007/s00441-016-2485-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  44 in total

Review 1.  Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.

Authors:  Shyamal Desai; Meredith Juncker; Catherine Kim
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-09

Review 2.  The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.

Authors:  Sayantan Datta; Marisol Cano; Katayoon Ebrahimi; Lei Wang; James T Handa
Journal:  Prog Retin Eye Res       Date:  2017-03-20       Impact factor: 21.198

Review 3.  Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases.

Authors:  Amaneh Mohammadi Roushandeh; Yoshikazu Kuwahara; Mehryar Habibi Roudkenar
Journal:  Cytotechnology       Date:  2019-01-31       Impact factor: 2.058

Review 4.  Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure.

Authors:  You Wu; Yong-Ming Yao; Zhong-Qiu Lu
Journal:  J Mol Med (Berl)       Date:  2019-02-21       Impact factor: 4.599

5.  Autophagy accounts for approximately one-third of mitochondrial protein turnover and is protein selective.

Authors:  Evelyn S Vincow; Ruth E Thomas; Gennifer E Merrihew; Nicholas J Shulman; Theo K Bammler; James W MacDonald; Michael J MacCoss; Leo J Pallanck
Journal:  Autophagy       Date:  2019-03-21       Impact factor: 16.016

Review 6.  Mitochondrial quality control in AMD: does mitophagy play a pivotal role?

Authors:  Juha M T Hyttinen; Johanna Viiri; Kai Kaarniranta; Janusz Błasiak
Journal:  Cell Mol Life Sci       Date:  2018-05-18       Impact factor: 9.261

7.  Stendomycin selectively inhibits TIM23-dependent mitochondrial protein import.

Authors:  Ireos Filipuzzi; Janos Steffen; Mitchel Germain; Laetitia Goepfert; Michael A Conti; Christoph Potting; Raffaele Cerino; Martin Pfeifer; Philipp Krastel; Dominic Hoepfner; Julie Bastien; Carla M Koehler; Stephen B Helliwell
Journal:  Nat Chem Biol       Date:  2017-10-09       Impact factor: 15.040

8.  Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages.

Authors:  Soo-Ho Choi; Colin Agatisa-Boyle; Ayelet Gonen; Alisa Kim; Jungsu Kim; Elena Alekseeva; Sotirios Tsimikas; Yury I Miller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-24       Impact factor: 8.311

Review 9.  OMA1-An integral membrane protease?

Authors:  Marcel V Alavi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-10-29       Impact factor: 3.036

10.  Adiponectin deficiency induces mitochondrial dysfunction and promotes endothelial activation and pulmonary vascular injury.

Authors:  Dilip Shah; Claudio Torres; Vineet Bhandari
Journal:  FASEB J       Date:  2019-10-04       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.